PARIBUS NORTH ENERGY

Brand Owner (click to sort) Address Description
PARIBUS NORTHENERGY Northenergy AG Palmaille 33 Hamburg 22767 Germany PARIBUS NORTH ENERGY;wind and water energy plants, oil-fired or coal-fired power stations; gas turbine power stations, atomic energy stations, thermal power stations, co-generation power stations, pumped hydro facilities and compressed air power stations for the production and supply of energy; wind energy systems, comprising of windmills, inverters, transformers; plants and facilities for the solar-thermal utilization of solar energy, assembly groups and parts therefor; solar collectors; warmth absorbers, heat exchangers, heat storages, heat pumps; assembly groups and parts therefor;
PARIBUS NORTHENERGY Northenergy AG Palmaille 33 Hamburg 22767 Germany PARIBUS NORTH ENERGY;Development of solar systems, photovoltaic systems, solar energy systems, hydro-power plants, oil-fired or coal fired power stations, gas turbine power stations, atomic energy stations, thermal power stations, co-generation power stations, pumped hydro facilities or compressed air power stations, wind energy systems, wind turbines, wind-operated machines and their parts for others, technical advice and information relating to the development of the above products and services; providing technological and scientific consultation concerning wind energy and how it operates; research and development in the field of regenerative energy production; technical advice in the nature of scientific advice on environmental protection in the field of regenerative energy production;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides isolated polynucleotide molecules, including plasmids; viral vectors; and transfected host cells that comprise a DNA sequence encoding an infectious RNA sequence encoding a North American PRRS virus; and also North American PRRS viruses encoded thereby. The invention further provides isolated infectious RNA molecules encoding a North American PRRS virus. The invention also provides isolated polynucleotide molecules, infectious RNA molecules, viral vectors, and transfected host cells encoding genetically-modified North American PRRS viruses; and genetically-modified North American PRRS viruses encoded thereby. The invention also provides vaccines comprising such plasmids, RNA molecules, viral vectors, and North American PRRS viruses, and methods of using these vaccines in swine and in other animals. Also provided are isolated polynucleotide molecules, viral vectors, and transfected host cells that comprise a nucleotide sequence encoding a peptide of a North American PRRS virus. These viral vectors and transfected host cell lines are useful in providing peptides to compensate for mutated peptide coding sequences of DNA sequences encoding genetically-modified North American PRRS viruses so that functional virions can be generated.